Safety of beta blockers for the treatment of PHACE syndrome: A systematic reviewAlexandra Finstad, Cathryn Sibbald, Yuliya Lytvyn et al.|Journal of the American Academy of Dermatology|2025Cited by 3
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) GroupKanika Kamal, Arash Mostaghimi, Angelo Valerio Marzano et al.|Journal of Investigative Dermatology|2023Cited by 2
38: Safety of Beta Blockers for the Treatment of PHACE SyndromeAlexandra Finstad, Cathryn Sibbald, Elena Pope et al.|Journal of Investigative Dermatology|2025Cited by 0